194 related articles for article (PubMed ID: 3034143)
1. Demonstration of viral thymidine kinase inhibitor and its effect on deoxynucleotide metabolism in cells infected with herpes simplex virus.
Nutter LM; Grill SP; Dutschman GE; Sharma RA; Bobek M; Cheng YC
Antimicrob Agents Chemother; 1987 Mar; 31(3):368-74. PubMed ID: 3034143
[TBL] [Abstract][Full Text] [Related]
2. Suppression of ocular herpes recurrences by a thymidine kinase inhibitor in squirrel monkeys.
Kaufman HE; Varnell ED; Cheng YC; Bobek M; Thompson HW; Dutschman GE
Antiviral Res; 1991 Oct; 16(3):227-32. PubMed ID: 1666825
[TBL] [Abstract][Full Text] [Related]
3. Clinical isolate of herpes simplex virus type 2 that induces a thymidine kinase with altered substrate specificity.
Ellis MN; Keller PM; Fyfe JA; Martin JL; Rooney JF; Straus SE; Lehrman SN; Barry DW
Antimicrob Agents Chemother; 1987 Jul; 31(7):1117-25. PubMed ID: 2821890
[TBL] [Abstract][Full Text] [Related]
4. Preferential inhibition of 5-trifluoromethyl-2'-deoxyuridine phosphorylation by 5'-amino-5'-deoxythymidine in uninfected versus herpes simplex virus-infected cells.
Fischer PH; Murphy DG; Kawahara R
Mol Pharmacol; 1983 Jul; 24(1):90-6. PubMed ID: 6408395
[TBL] [Abstract][Full Text] [Related]
5. Isolation of bromovinyldeoxyuridine-resistant strains of herpes simplex virus and successful chemotherapy of mice infected with one such strain by using acyclovir.
Field HJ; Neden J
Antiviral Res; 1982 Oct; 2(5):243-54. PubMed ID: 6295272
[TBL] [Abstract][Full Text] [Related]
6. Metabolism and mode of action of (R)-9-(3,4-dihydroxybutyl)guanine in herpes simplex virus-infected vero cells.
Stenberg K; Larsson A; Datema R
J Biol Chem; 1986 Feb; 261(5):2134-9. PubMed ID: 2418021
[TBL] [Abstract][Full Text] [Related]
7. Deoxythymidine kinase induced in the HELA TK- cells by herpes simplex virus type I and type II. Substrate specificity and kinetic behavior.
Cheng YC
Biochim Biophys Acta; 1976 Dec; 452(2):370-81. PubMed ID: 188465
[TBL] [Abstract][Full Text] [Related]
8. N2-phenyldeoxyguanosine: a novel selective inhibitor of herpes simplex thymidine kinase.
Focher F; Hildebrand C; Freese S; Ciarrocchi G; Noonan T; Sangalli S; Brown N; Spadari S; Wright G
J Med Chem; 1988 Aug; 31(8):1496-500. PubMed ID: 2840499
[TBL] [Abstract][Full Text] [Related]
9. Deoxyribonucleoside triphosphate pools in herpes simplex type 1 infected cells.
Jamieson AT; Bjursell G
J Gen Virol; 1976 Apr; 31(1):101-13. PubMed ID: 177722
[TBL] [Abstract][Full Text] [Related]
10. Effects of ribonucleotide reductase inhibition on pyrimidine deoxynucleotide metabolism in acyclovir-treated cells infected with herpes simplex virus type 1.
Karlsson A; Harmenberg J
Antimicrob Agents Chemother; 1988 Jul; 32(7):1100-2. PubMed ID: 2847642
[TBL] [Abstract][Full Text] [Related]
11. Low levels of herpes simplex virus thymidine- thymidylate kinase are not limiting for sensitivity to certain antiviral drugs or for latency in a mouse model.
Coen DM; Irmiere AF; Jacobson JG; Kerns KM
Virology; 1989 Feb; 168(2):221-31. PubMed ID: 2536980
[TBL] [Abstract][Full Text] [Related]
12. Biochemical basis for increased susceptibility to Cidofovir of herpes simplex viruses with altered or deficient thymidine kinase activity.
Mendel DB; Barkhimer DB; Chen MS
Antimicrob Agents Chemother; 1995 Sep; 39(9):2120-2. PubMed ID: 8540727
[TBL] [Abstract][Full Text] [Related]
13. Deoxyribonucleotide metabolism in Herpes simplex virus infected HeLa cells.
Cheng YC; Goz B; Prusoff WH
Biochim Biophys Acta; 1975 May; 390(3):253-63. PubMed ID: 164949
[TBL] [Abstract][Full Text] [Related]
14. Antiviral activity of the 3'-amino derivative of (E)-5-(2-bromovinyl)-2'-deoxyuridine.
De Clercq E; Descamps J; Balzarini J; Fukui T; Allaudeen HS
Biochem J; 1983 May; 211(2):439-45. PubMed ID: 6307280
[TBL] [Abstract][Full Text] [Related]
15. L-thymidine is phosphorylated by herpes simplex virus type 1 thymidine kinase and inhibits viral growth.
Spadari S; Maga G; Focher F; Ciarrocchi G; Manservigi R; Arcamone F; Capobianco M; Carcuro A; Colonna F; Iotti S
J Med Chem; 1992 Oct; 35(22):4214-20. PubMed ID: 1331461
[TBL] [Abstract][Full Text] [Related]
16. Properties of purified enzymes induced by pathogenic drug-resistant mutants of herpes simplex virus. Evidence for virus variants expressing normal DNA polymerase and altered thymidine kinase.
Larder BA; Derse D; Cheng YC; Darby G
J Biol Chem; 1983 Feb; 258(3):2027-33. PubMed ID: 6296119
[TBL] [Abstract][Full Text] [Related]
17. 9-(3,4-dihydroxybutyl)guanine, a new inhibitor of herpesvirus multiplication.
Larsson A; Oberg B; Alenius S; Hagberg CE; Johansson NG; Lindborg B; Stening G
Antimicrob Agents Chemother; 1983 May; 23(5):664-70. PubMed ID: 6307131
[TBL] [Abstract][Full Text] [Related]
18. 2,3-Dihydroxy-quinoxaline induces ATPase activity of Herpes Simplex Virus thymidine kinase.
Zeifman AA; Novikov FN; Stroylov VS; Stroganov OV; Chilov GG; Skoblov AY; Miroshnikov AI; Skoblov YS
FEBS Lett; 2014 Jan; 588(3):509-11. PubMed ID: 24374341
[TBL] [Abstract][Full Text] [Related]
19. Anti-herpes simplex virus and anti-human cell growth activity of E-5-propenyl-2'-deoxyuridine and the concept of selective protection in antivirus chemotherapy.
Cheng YC; Grill S; Ruth J; Bergstrom DE
Antimicrob Agents Chemother; 1980 Dec; 18(6):957-61. PubMed ID: 6263181
[TBL] [Abstract][Full Text] [Related]
20. 2'-fluoro-5-iodo-aracytosine, a potent and selective anti-herpesvirus agent.
Lopez C; Watanabe KA; Fox JJ
Antimicrob Agents Chemother; 1980 May; 17(5):803-6. PubMed ID: 6249196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
